|
Nucleoside reverse transcriptase inhibitors (NRTIs) |
|
Zidovudine (AZT) |
Retrovir |
GlaxoSmithKline |
Didanosine (ddI) |
Videx |
Bristol Myers-Squibb |
Zalcitabine (ddC) |
Hivid |
Hoffmann-La Roche |
Stavudine (d4T) |
Zerit |
Bristol Myers-Squibb |
Lamivudine (3TC) |
Epivir and Zeffix |
GlaxoSmithKline |
Abacavir sulfate (ABC) |
Ziagen |
GlaxoSmithKline |
Emtricitabine (FTC) |
Emtriva |
Gilead Sciences, Inc. |
|
Nucleotide reverse transcriptase inhibitors (NtRTIs) |
|
Tenofovir disoproxil fumarate |
Viread |
Gilead Sciences, Inc. |
|
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) |
|
Nevirapine (NVP) |
Viramune |
Boehringer Ingelheim |
Delavirdine (DLV) |
Rescriptor |
Pfizer |
Efavirenz (EFV) |
Sustiva and Stocrin |
Bristol Myers-Squibb |
Entavirine (TMC125) |
Intelence |
Tibotec, Inc. |
|
Protease inhibitors (PIs) |
|
Saquinavir mesylate (SQV) |
Invirase and Fortovase |
Hoffmann-La Roche |
Ritonavir |
Norvir |
Abott Laboratories |
Indinavir (IND) |
Crixivan |
Merck & Co., Inc. |
Nelfinavir mesylate (NFV) |
Viracept |
Agouron Phramaceuticals |
Amprenavir |
Agenerase and Prozei |
GlaxoSmithKline |
Fosamprenavir calcium (Prodrug of amprenavir) |
Lexiva and Telzir |
GlaxoSmithKline |
Atazanavir sulfate |
Reyataz |
Bristol Myers-Squibb |
Lopinavir and ritonavir |
Kaletra |
Abott Laboratories |
Tipranavir |
Aptivus |
Boehringer Ingelheim |
Darunavir |
Prezista |
Tibotec, Inc. |
|
Entry and fusion inhibitors |
|
Maraviroc |
Salzentry |
Pfizer |
Enfuvirtide |
Fuzeon |
Hoffmann-La Roche, Trimeris |
|
Integrase inhibitors |
|
Raltegravir |
Isentress |
Merck & Co., Inc. |